Paper1253124
The cardiotoxicity of adriamycin and daunomycin in children.
Gilladoga AC and 5 others. Cancer, 1976. Cited by 152 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The cardiotoxicity of adriamycin and daunomycin in children. Papers, record 1253124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1253124
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Daunorubicin | Major topic |
| Doxorubicin | Major topic |
| Heart Diseases | Major topic |
| Adolescent | |
| Child | |
| Digitalis Glycosides | |
| Dose-Response Relationship, Drug | |
| Electrocardiography | |
| Heart Failure | |
| Humans | |
| Neoplasms |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 152 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,393,712 | The mitochondrial protease, LonP1, is a potential cardioprotective target for attenuating doxorubicin-induced cardiomyocyte death. | J Transl Med | 2026 | https://conductscience.org/library/papers/42393712 | PubMed |
| 40,460,832 | Visceral fat lipolysis by pancreatic lipases worsens heart failure. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40460832 | PubMed |
| 39,860,645 | Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection Bias. | J Clin Med | 2025 | https://conductscience.org/library/papers/39860645 | PubMed |
| 35,764,701 | Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35764701 | PubMed |
| 34,396,324 | Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization. | JACC CardioOncol | 2021 | https://conductscience.org/library/papers/34396324 | PubMed |
| 33,740,233 | Chia Seed Oil Ameliorates Doxorubicin-Induced Cardiotoxicity in Female Wistar Rats: An Electrocardiographic, Biochemical and Histopathological Approach. | Cardiovasc Toxicol | 2021 | https://conductscience.org/library/papers/33740233 | PubMed |
| 33,510,932 | Methyl Gallate Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Suppressing Oxidative Stress. | Scientifica (Cairo) | 2021 | https://conductscience.org/library/papers/33510932 | PubMed |
| 33,185,690 | CYP1B1 as a therapeutic target in cardio-oncology. | Clin Sci (Lond) | 2020 | https://conductscience.org/library/papers/33185690 | PubMed |
| 32,766,291 | Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study. | Front Vet Sci | 2020 | https://conductscience.org/library/papers/32766291 | PubMed |
| 31,187,890 | Doxorubicin-Induced Cardiomyopathy in Children. | Compr Physiol | 2019 | https://conductscience.org/library/papers/31187890 | PubMed |
| 30,875,799 | Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology. | Nutrients | 2019 | https://conductscience.org/library/papers/30875799 | PubMed |
| 30,770,843 | A computational study of Anthracyclines interacting with lipid bilayers: Correlation of membrane insertion rates, orientation effects and localisation with cytotoxicity. | Sci Rep | 2019 | https://conductscience.org/library/papers/30770843 | PubMed |
| 30,310,418 | Chemotherapy-related Cardiomyopathy. | Eur Cardiol | 2015 | https://conductscience.org/library/papers/30310418 | PubMed |
| 28,452,856 | Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes. | J Pediatr Hematol Oncol | 2017 | https://conductscience.org/library/papers/28452856 | PubMed |
| 27,142,468 | Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes. | Sci Rep | 2016 | https://conductscience.org/library/papers/27142468 | PubMed |
| 26,862,121 | Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. | Cardiovasc Res | 2016 | https://conductscience.org/library/papers/26862121 | PubMed |
| 26,722,406 | Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26722406 | PubMed |
| 26,198,095 | An experimental approach to study the function of mitochondria in cardiomyopathy. | BMB Rep | 2015 | https://conductscience.org/library/papers/26198095 | PubMed |
| 25,134,924 | Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers. | Paediatr Drugs | 2014 | https://conductscience.org/library/papers/25134924 | PubMed |
| 23,361,962 | Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician. | Eur J Pediatr | 2013 | https://conductscience.org/library/papers/23361962 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1253124
GET https://conductscience.org/api/papers/v1/1253124/cited_by?page=2